Clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.

Sectors
Healthcare
Life Sciences
First Invested
2019
Public/PIPES
Company Status
NASDAQ: XENE